A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).

Ann Oncol · 2016 · PMC4922318 · PMID 27056996

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

The results of the subgroup analysis of RFS showed a significant interaction between regimen and age (<70 versus ≥70 years) and marginally significant interactions of regimen with sex (male/female) and with T factor (T1, 2/T3, 4).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.